Actively Recruiting
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant Bronchopulmonary Dysplasia Through Exercise (FLASHLITE)
Led by Masonic Cancer Center, University of Minnesota · Updated on 2025-11-24
90
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying exercise intolerance and the ability to assess heart and lung function and exercise capacity in young people with chronic childhood diseases. The conditions included are acute lymphoblastic leukemia survivors, chronic lung disease of prematurity, and those who have had a heart transplant. The goal is to better understand exercise limitations and help guide future exercise recommendations for this growing population as they age into adulthood. Participants include adolescents and young adults from 8 to 25 years old, including healthy controls for comparison. The study involves one visit lasting 3 to 4 hours during which participants undergo exercise testing to measure peak oxygen intake and heart function. Participants also provide information about their physical activity and perceived fitness. Both cases and healthy controls are ambulatory and meet specific health criteria. During the visit, researchers measure lung function, cardiac output, and exercise capacity using non-invasive testing. They also assess expiratory flow limitation and link heart function to patient-reported fitness levels. The study uses questionnaires completed on paper or electronically to gather activity data. The researchers aim to collect detailed data in a single visit to better characterize exercise capacity and limitations in these groups.
CONDITIONS
Brief Title
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Acute lymphoblastic leukemia survivor, or living with chronic lung disease of prematurity, or living with heart transplant (for cases)
- Age between 8 and 25 years
- Height of at least 48 inches
- Able to walk without assistance
- English speaking
- Normal blood pressure (below 95th percentile for age, controlled if on medication)
- Oxygen saturation above 92% (cases) or above 95% (controls)
- Not pregnant
- ALL survivors must have finished therapy at least 3 months before the study
- Healthy controls aged 8 to 25 without known heart or lung disease
- Controls must have no history of arrhythmia or cardiac dysfunction
You will not qualify if you...
- ALL survivors who received cranial radiation
- Bone marrow transplant recipients
- History of cancer, chronic lung disease, heart transplant, or other diagnosis reducing heart or lung function (controls)
- Investigator or primary physician considers participant unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants complete physical activity questionnaires and undergo exercise testing to assess peak oxygen intake, cardiac output, and expiratory flow limitation.
1 onetime study visit lasting 3-4 hours (in-person)
Trial Site Locations
Total: 1 location
1
Masonic Cancer Center
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
C
Char Napurski, MPH, CCRP
P
Pianosi Paolo, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here